The Selective Anti Leukemic Effect of BL-8040, a Peptidic CXCR4 Antagonist, Is Mediated By Induction of Leukemic Blast Mobilization, Differentiation and Apoptosis: Results of Correlative Studies from a Ph2a Trial in Acute Myeloid Leukemia
Year: 2016
Type: article
Source: Blood
Authors: Gautam Borthakur, Martin S. Tallman, Yishai Ofran, James M. Foran, Geoffrey L Uy, John F DiPersio, Arnon Nagler, Jacob M. Rowe, Margaret M. Showel, Jessica Altman, Ahmed Al-Rawi, Rui-Yu Wang, Amnon Peled, Michal Abraham, Yaron Pereg, Abi Vainstein, Galia Oberkovitz, Tzipi Lustig, Arnon Aharon, Carlos E. Bueso-Ramos, Jorge E. Cortes, Michael Andreeff
Institutions: The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Rambam Health Care Campus, Mayo Clinic in Florida, Washington University in St. Louis, Sheba Medical Center, Shaare Zedek Medical Center, Bikur Cholim Hospital, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Northwestern University, Biokine (Israel), BioLineRx Ltd. (Israel)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2744601730